|
|
|
|
|
| November 10, 2011 | ISSUE NUMBER 225 VOL 8 |
|
Deals
Turbulent Waters: The State of Pharma M&As 2011
The latest numbers in pharma deals reveals a sector in transition, where market volatility has sharply degraded the appetite for risk, writes Peter Young
...Read More
Policy
DHSS Weighs in on Drug Shortages
Just days after the White House issued an executive order directing FDA to take specific steps to predict and prevent drug shortages, the Department of Health and Human Services releases a report analyzing the causes of the drug shortage escalation ...Read More
Safety
Accelerated Approvals Could Raise Patient Risk
The high number of FDA approvals this year could be as much a cause for concern as the Agency’s lower approval rate during 2009 and 2010 ...Read More
Advertisement
Leadership and Strategy in Pharmaceuticals and Biotech
 http://www.exed.hbs.edu/programs/lspb/Pages/default.aspx
Revolutions in technology, markets, and government policy are transforming the playing field for pharmaceutical and biotechnology companies. This program prepares high-potential executives to become better managers and leaders by presenting new ways to manage risk, foster innovation, and capitalize on emerging opportunities. |
Big Pharma
Sanofi Top Pharma Co by 2012?
Next year may see Pfizer usurped from its throne by Sanofi and Novartis, who will claim pole and second positions, respectively, in the global pharmaceutical rankings, according to research from EvaluatePharma ...Read more
| Advertisement |
| |
 |
| |
|
A Pragmatist's Guide To Building A Business Case For ERP
Leveraging survey results from her firm’s 2011 ERP Solution Study, Cindy Jutras, a leading enterprise analyst, offers practical advice in building one’s business case for a formula-based ERP application, including top operational goals, key performance expectations, ROI timeline and cloud vs on-premise platform decision.
 Read White Paper |
Global
Read the Latest Pharm Exec Global Digest
Features this month cover recruitment in the era of lean; new horizons for biopharm outsourcing; optimizing market access efforts; and the ongoing information to patients debate in Europe ...Read more
Educational Video:
Improving Clinical Operations with Digital Signatures
The majority of large CROs and Pharmas are using digital signatures to speed clinical site initiation, reduce site monitoring reporting costs, and improve audit efficiency.  Watch this short video to learn how digital signatures enable these benefits and others. |
 |
|
|
|
|
 // Roche (Nutley, NJ) announced that Pamela Carroll, Ph.D., has joined the company as Nutley Oncology Discovery Site Head and Global Head, Pathways Biology within Pharma Research and Early Development (pRED).
// Ralph S. Tyler, most recently Chief Counsel of the FDA and former Insurance Commissioner of the State of Maryland, has joined Venable (Baltimore) as a Partner.// Catalent Pharma Solutions (Somerset, NJ) appointed Jonathan Arnold as Vice President and General Manager, Sterile Technologies, effective immediately.// Theorem Clinical Research (King of Prussia, PA), previously Omnicare Clinical Research, recruited Marc Hoffman, MD, as Senior Vice President and General Manager for its newly formed Pharmaceutical Development Business Unit.// BioNano Genomics (San Diego) elected Albert Luderer, Ph.D., to its Board of Directors.// The Society of Pharmaceutical and Biotech Trainers (SPBT; Roanoke, VA) elected Carol Wells to its Board of Directors, effective January 1, 2012.
|
|
|
|
|
|
|
|
 |
|
 |
| |
 |
 |
|
 |
| What is your company's main driver for outsourcing biologics?
|
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
